Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
about
Trimetazidine for stable anginaWITHDRAWN: Trimetazidine for stable angina.Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" - not "end-stage" after allComparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial.Efficacy of Ligustrazine Injection as Adjunctive Therapy for Angina Pectoris: A Systematic Review and Meta-Analysis.Ischemic heart disease: metabolic approaches to management.Executive Summary of the Guidelines on Stable Coronary Disease.Metabolic modulators for chronic cardiac ischemia.Evolving treatment strategies for chronic refractory angina.Metabolic therapeutics in angina pectoris: history revisited with perhexiline.Ranolazine in patients with coronary artery disease.Utility of ranolazine in chronic stable angina patients.Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.Overview of emerging pharmacotherapy in chronic heart failure.Pharmacological strategies against cold ischemia reperfusion injury.Emerging medical treatment for angina pectoris.Efficacy of metabolic modulators in ischemic heart disease: an overview.Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.Trimetazidine and cardioprotection: facts and perspectives.Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.Antianginal Therapy for Stable Ischemic Heart Disease.Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.Reduction of postoperative adhesions by trimetazidine: an experimental study in a rat model.
P2860
Q24245946-79C19790-DD44-414A-805F-483C89227AC4Q30400121-20BEDB31-664A-4BF5-8E83-3A4CDB268189Q33498122-DFCD3C7E-E8AF-44C7-9536-CF01D966CF1AQ35139678-ED32906D-F600-4A10-B876-BA0874C4AAF8Q35854874-99293345-EF05-4713-B394-67D982A667E5Q35878082-70EF3EDC-3D44-4FA6-95CE-163B0CBC2CDFQ36248124-CA82EDBB-5473-421B-8D24-C26A286F68B0Q36355273-981E0087-BD9B-476B-879E-562DA1BBD092Q36382563-77D9E6DE-6144-4CF0-93D9-837D5909DDBDQ36392401-52B2D644-0E61-463A-AF9D-09F75A5C2B43Q36916931-3ED8E68B-BDD4-4D00-AB7E-76CEB4C0D279Q37004023-3449B332-1F39-4A07-B2D3-05DFF460CFB1Q37012951-401B4736-8A5B-460A-BDFF-965FA4507AADQ37457580-08567142-3FF2-4789-A897-20E2F358703DQ37552943-11DDA2EB-5C4C-4297-BA8D-39DCCEB49F34Q37693921-734793A6-F24E-4CBC-A0BA-2E1B02DC36D1Q37729183-2C0E1E6C-336B-4723-9215-F0F8D1EE283BQ37850633-43D1CA33-097E-4E5B-8530-D6AFBE66A8B2Q37871496-526CA6BC-E742-4B42-9505-CA7FA3E3B223Q38203492-92909AEF-5E3C-46C1-ABF6-2C89148CA513Q38217985-DA0CE011-C3C3-4DE4-A254-30256207CA1FQ38732082-3098B6B9-DA7F-4563-98EA-C1935DF92B41Q39157629-067123BD-E413-4CEE-A30A-B78B0ABAD85EQ45829479-7A340B99-DD20-45B7-B812-FA3643AF7583Q51414977-4F8B0896-D0E9-4BDB-A99C-476B7DDAC05D
P2860
Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@ast
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@en
type
label
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@ast
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@en
prefLabel
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@ast
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@en
P1476
Efficacy and tolerability of t ...... uble-blind, controlled trials.
@en
P2093
Mario Marzilli
Werner W Klein
P304
P356
10.1097/00019501-200304000-00010
P577
2003-04-01T00:00:00Z